MnM_logo_TM_JPG.JPG
Continuous Renal Replacement Therapy Market is Expected to Reach $2.1 Billion | MarketsandMarkets.
19. Dezember 2023 18:30 ET | MarketsandMarkets Research Pvt. Ltd.
Chicago, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Continuous Renal Replacement Therapy market in terms of revenue was estimated to be worth $1.4 Billion in 2023 and is poised to reach $2.1 billion by 2028,...
Continuous Renal Replacement Therapy Market
Global Continuous Renal Replacement Therapy Market is expected to grow at a CAGR of ~7-9% by 2027 : A Life-Sustaining & Life-Saving Therapy
02. Mai 2023 09:30 ET | Medi-Tech Insights
BRUSSELS, BELGIUM, May 02, 2023 (GLOBE NEWSWIRE) -- Continuous Renal Replacement Therapy (CRRT) is a slow and gentle form of dialysis that removes excess fluids and waste products from the blood...
MnM_logo_TM_JPG.JPG
Continuous Renal Replacement Therapy (CRRT) Market to Cross $1.7 billion by 2026 - Exclusive Report by MarketsandMarkets™
02. Februar 2023 20:45 ET | MarketsandMarkets Research Pvt. Ltd.
Chicago, Feb. 02, 2023 (GLOBE NEWSWIRE) -- According to the new market research report Published by MarketsandMarkets, "Continuous Renal Replacement Therapy Market by Product (Disposables...
FBI LOGO TM.png
Continuous Renal Replacement Therapy (CRRT) Market to Reach USD 1,811.5 Million by 2027: Rising Prevalence of Chronic Diseases to Add Momentum, says Fortune Business Insights™
11. August 2020 11:51 ET | Fortune Business Insights
Pune, Aug. 11, 2020 (GLOBE NEWSWIRE) -- The global continuous renal replacement therapy market size is expected to gain momentum and reach USD 1,811.5 million by 2027 on account of the increasing...
FBI LOGO TM.png
Continuous Renal Replacement Therapy Market to Exhibit 7.5% CAGR; High Incidence of Hypertension to Propel Growth, says Fortune Business Insights™
06. April 2020 04:52 ET | Fortune Business Insights
Pune, April 06, 2020 (GLOBE NEWSWIRE) -- The global continuous renal replacement therapy (CRRT) market is set to be positively impacted by rising technological advancements by renowned acute therapy...